• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: February 2021

Finance

Ferring, Rebiotix and MyBiotics Collaborate to Develop Microbiome Therapeutics in Reproductive Medicine and Maternal Health

February 19, 2021 Microbiome Times

Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age […]

Pharma & Human Health

Smectite promotes probiotic biofilm formation in gut for cancer immunotherapy

February 15, 2021 Microbiome Times

Scientists from Nanjing University and the University of Macau have devised a new approach to extend the survival of transplanted probiotics in vivo, enhancing the efficacy of cancer chemo-/immunotherapies in mice. The paper entitled “Smectite […]

Finance

Global biotech executive to boost microbiome drug development for Asia Pacific

February 11, 2021 Microbiome Times

Global biotech executive Thomas Mitchell is set to drive growth, innovation and expansion across Asia Pacific for thriving biotechnology start-up BiomeBank, Australia’s first public stool bank and microbiome therapeutics company, bringing with him a wealth […]

Lallemand Health Solutions

Probiotics to Provide Holistic Health Benefits

February 10, 2021 Microbiome Times

A healthy mind in a healthy body is a widely used mantra, now even more relevant than ever before. Since 2020, consumers’ behavior has evolved: 64% are now more conscious about their immunity and 43% […]

Editor's Choice

Fecal transplant turns cancer immunotherapy non-responders into responders

February 10, 2021 Microbiome Times

Fecal transplant changes the gut microbiome, turning cancer immunotherapy non-responders into responders. Video Credits: UNIVERSITY OF PITTSBURGH   Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut […]

Pharma & Human Health

Investigating the removal of dry biofilm with probiotic cleansers

February 9, 2021 Microbiome Times

A CONCEPT known as dry biofilms has emerged over the past few years and they have shown to frequently harbour potentially infectious organisms, just like the ones present in Hospital Acquired Infections (HAIs). However, as […]

Pharma & Human Health

MIND and Mediterranean diets associated with later onset of Parkinson’s disease

February 5, 2021 Microbiome Times

A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson’s disease (PD). While researchers have long known of neuroprotective effects of the MIND […]

Pharma & Human Health

Lactobacillus manipulates bile acids to create favorable gut environment

February 4, 2021 Microbiome Times

New research from North Carolina State University reveals that probiotic Lactobacillus bacteria use enzymes situationally to manipulate bile acids and promote their own survival in the gut. These findings further elucidate the complicated relationship between […]

Pharma & Human Health

Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate Phase 3 Clinical Trial Evaluating Microbiome Protector DAV132

February 3, 2021 Microbiome Times

Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to prevent the life-threatening effects antibiotics have on the gut microbiome of cancer patients, announced today that it received approval to start enrolling patients in a […]

Reports

Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine

February 3, 2021 Luis Gosálbez

Abstract Knowledge about the human microbiome is requiring scientists to re-define the relationship between microbes and disease, going beyond Koch’s Postulates and incorporating concepts such as holobiont – understanding human physiology as the sum of […]

Premium Content

Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine

February 2, 2021 Luis Gosálbez

Abstract Knowledge about the human microbiome is requiring scientists to re-define the relationship between microbes and disease, going beyond Koch’s Postulates and incorporating concepts such as holobiont – understanding human physiology as the sum of […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter